|Articles|September 1, 2002
IPO positions Alcon for tomorrow
Author(s)Mark L. Dlugoss
Fort Worth, TX-Amid the fanfare of the New York Stock Exchange and company executives, Tim Sear of Alcon Laboratories Inc. and Peter Brabeck-Letmathe of Nestl? A stood atop the balcony overlooking the trading floor and rang the opening bell, marking the official start of the day on Wall Street.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
NeuroOp Guru: When proptosis isn’t thyroid eye disease
2
FDA clears BVI’s FineVision HP trifocal IOL for the US market
3
FDA approves Rayner’s RayOne EMV Toric intraocular lens
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5